100XBIO
100XBIO develops single-cell and spatial biology technologies enabling high-resolution cellular analysis for research and drug discovery.
Pre Seed ·
Amount not disclosed in a source on record.
Funding history ↓About 100XBIO
100XBIO is a company based in Woburn, United States. Recent Funding lists it under Health and bio. Its latest known round is a Pre Seed round (October 2026); no sourced amount is on record for it yet. It was founded by Sergei Pull (Pustylnikov), Sofya Leyn and Timofei Bondarev.
100XBIO | 1287 days from website to first raise on record
One step per dated milestone. Pins are dated signals; hover the icons for dates.
Funding rounds
- Pre Seed · amount undisclosed
- X account created
- Website created
Founders and team
SP
Sergei Pull (Pustylnikov) FounderSL
Sofya Leyn FounderTB
Timofei Bondarev Founder
Similar Health and bio companies
HHexagon Bio$62M Series B+ · Oct 2026
HHeyVoli$500K Pre Seed · Oct 2026
VVitalls$1.5M Seed · Oct 2026WWarp Sciences$215M Series A · Oct 2026
PPAM2L Biotechnologies$29.97M Series A · Oct 2026
CCureBay$10.55M Series B+ · Oct 2026
Questions and sources
100XBIO: questions and answers
- Who founded 100XBIO?
- 100XBIO was founded by Sergei Pull (Pustylnikov), Sofya Leyn and Timofei Bondarev.
- Where is 100XBIO based?
- 100XBIO is based in Woburn, United States.
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/100xbio (get a free API key).